Merck (MRK) EBT Margin (2009 - 2026)

Merck (MRK) has reported EBT Margin for 18 consecutive years, with 4.11% the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT Margin fell 3574.0% year-over-year to 4.11% in Q2 2026; TTM through Jun 2026 was 8.94%, a 2119.0% decrease from a year earlier, with the FY2025 full-year figure at 32.41%, up 134.0% from the prior year.
• EBT Margin was 4.11% for Q2 2026 at Merck, up from 21.7% in the prior quarter.
• Over five years, EBT Margin peaked at 39.04% in Q3 2025 and troughed at 35.48% in Q2 2023.
• A 5-year average of 19.43% and a median of 26.05% in 2022 frame the typical range for EBT Margin.
• Across the five-year window, EBT Margin sank 6623 bps in 2023 and soared 7276 bps in 2024, its largest moves.
• Over 5 years, EBT Margin stood at 25.4% in 2022, then plunged by 155 bps to 13.98% in 2023, then soared by 291 bps to 26.69% in 2024, then retreated by 22 bps to 20.85% in 2025, then slumped by 120 bps to 4.11% in 2026.
• The last three EBT Margin figures came in at 4.11% (Q2 2026), 21.7% (Q1 2026), and 20.85% (Q4 2025), per Business Quant data.